Q1 FY2027 Activities Update Manufacturing scale. Commercial execution. International growth. ASX: BLS | October 2026 DISCLAIMER This presentation (Presentation) has been prepared by BLS Pharmaceuticals Limited ABN 97 084 464 193 No party other than BLS has authorised or caused the issue, lodgement,...